Staurenza Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 7 years ago on Monday, August 29, 2016, according to the United State Patent & Trademark Office

Word Mark	Staurenza
Status	Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Denovo Biopharma, LLC of San Diego, CA

View all trademarks for Denovo Biopharma, LLC

Other Trademarks for Denovo Biopharma, LLC

Previous Owners

Eli Lilly and Company of Indianapolis, IN

View all trademarks for Eli Lilly and Company

Other Trademarks for Eli Lilly and Company

Serial Number	85793104
Status Date	Monday, August 29, 2016
Filing Date	Monday, August 29, 2016
Attorney	Jennifer Lee Taylor

Correspondent

Jennifer Lee Taylor
Morrison & Foerster LLP
425 Market Street
San Francisco CA 94105-2482

Case File Statements

Goods & Services	Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	006, 018, 044, 046, 051, 052
Status	6 — Active
Status Date	Tuesday, December 11, 2012
Primary Code	005

Trademark Timeline

Dec 03 2012

Trademark application filed with USPTO
Dec 06 2012

New Application Entered In Tram
Dec 11 2012

New Application Office Supplied Data Entered In Tram
Mar 21 2013

Assigned To Examiner
Mar 22 2013

Examiner's Amendment Entered
Mar 22 2013

Notification of Examiners Amendment E-Mailed
Mar 22 2013

Examiners Amendment E-Mailed
Mar 22 2013

Examiners Amendment -Written
Mar 29 2013

Approved For Pub - Principal Register
Apr 19 2013

Assigned To Lie
Apr 23 2013

Law Office Publication Review Completed
May 08 2013

Notification of Notice of Publication E-Mailed
May 28 2013

Official Gazette Publication Confirmation E-Mailed
May 28 2013

Published For Opposition
Jul 23 2013

Noa E-Mailed - Sou Required From Applicant
Dec 06 2013

Extension 1 Filed
Dec 06 2013

Teas Extension Received
Jan 24 2014

Case Assigned To Intent To Use Paralegal
Jan 27 2014

Extension 1 Granted
Jan 28 2014

Notice of Approval of Extension Request E-Mailed
Jun 18 2014

Extension 2 Filed
Jun 18 2014

Teas Extension Received
Jun 24 2014

Extension 2 Granted
Jun 25 2014

Notice of Approval of Extension Request E-Mailed
Jan 23 2015

Extension 3 Filed
Jan 23 2015

Attorney Revoked And/or Appointed
Jan 23 2015

Teas Revoke/appoint Attorney Received
Jan 23 2015

Teas Change of Correspondence Received
Jan 23 2015

Teas Extension Received
Jan 28 2015

Automatic Update of Assignment of Ownership
Jan 29 2015

Extension 3 Granted
Jan 30 2015

Notice of Approval of Extension Request E-Mailed
Jul 09 2015

Extension 4 Filed
Jul 09 2015

Teas Extension Received
Jul 13 2015

Extension 4 Granted
Jul 14 2015

Notice of Approval of Extension Request E-Mailed
Sep 25 2015

Applicant/correspondence Changes (non-Responsive) Entered
Sep 25 2015

Teas Change of Owner Address Received
Jan 21 2016

Extension 5 Filed
Jan 21 2016

Teas Extension Received
Jan 28 2016

Extension 5 Granted
Jan 29 2016

Notice of Approval of Extension Request E-Mailed
Aug 29 2016

Abandonment Notice Mailed - No Use Statement Filed
Aug 29 2016

Abandonment - No Use Statement Filed